Keyphrases
Thailandepsin A
100%
Histone Deacetylase Inhibitor (HDACi)
100%
Cancer Growth
100%
Anaplastic Thyroid Cancer
100%
Extrinsic Apoptosis
37%
Cell Proliferation
25%
Flow Cytometry
25%
Antiproliferative Activity
25%
Apoptosis Markers
25%
Intrinsic Apoptosis
25%
Thyroid Cancer Cells
25%
Cell Cycle Proteins
25%
Protein Level
12%
Molecular Mechanism
12%
Caspase-3
12%
Western Blot Analysis
12%
Increased Dose
12%
Surgical Intervention
12%
Bcl-xL
12%
M Phase
12%
Cell Cycle Arrest
12%
B-cell Lymphoma 2 (Bcl-2)
12%
Anti-apoptotic Proteins
12%
IC50
12%
Colorimetric Assay
12%
Survivin
12%
Sigma Phase
12%
Apoptotic Cells
12%
Reduced Cell
12%
Polymerase
12%
Medical Intervention
12%
Adenosine Diphosphate Ribose
12%
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium Bromide
12%
Thyroid Cancer Cell Lines
12%
Polyadenosine
12%
Novel Class
12%
CDK Inhibitors
12%
Apoptosis Activators
12%
Propidium Iodide
12%
Preclinical Investigation
12%
Cell Growth Inhibition
12%
P21Cip1
12%
Cleaved Caspase
12%
Apoptosis Regulators
12%
Caspase-8
12%
Caspase-9
12%
Clinical Investigation
12%
Targeted Therapy
12%
Viable Cell Count
12%
Pharmacology, Toxicology and Pharmaceutical Science
Cancer Growth
100%
Histone Deacetylase Inhibitor
100%
Anaplastic Thyroid Carcinoma
100%
Flow Cytometry
28%
Cell Cycle Protein
28%
Western Blot
14%
Antiapoptotic
14%
Thyroid Cancer
14%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
14%
Caspase 9
14%
IC50
14%
Propidium Iodide
14%
Antiproliferative Activity
14%
Caspase 3
14%
Survivin
14%
Protein BAD
14%
3 (4,5 Dimethyl 2 Thiazolyl) 2,5 Diphenyltetrazolium Bromide
14%
Caspase 8
14%